Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2010-05-31
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study hypothesis: Routine use of SGW has no impact on the results of ureteroscopic treatment of urolithiasis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does a Safety Guidewire Increase the Forces Needed to Move the Ureteroscope up and Down the Ureter?
NCT01117701
Results of Safety Guidewire Use in Ureteroscopic Stone Surgery
NCT03108053
Comparing Uretersocopy With Versus Without Use of Guide-wire in Treatment of Ureteral Stone
NCT03726502
Primary Ureteroscopy for Acute Obstructive Nephropathy Due to Ureteral Stones: A Prospective Non-randomized Feasibility and Safety Trial
NCT07177313
Single-use Digital Flexible Ureteroscope vs Nondisposable Fiber Optic vs Digital Ureteroscope
NCT03220516
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, SGW may be an obstacle to efficient disintegration and retraction of calculi in the narrow ureter.
The intention of this study is to compare the results of endoscopic stone treatment with and without the use of SGW.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
B - without SGW
Ureteroscopy without SGW in place.
Ureteroscopy with and without safety guidewire
In study arm A - with SGW, endoscopic treatment is performed with a safety guidewire in place. In study arm B - without SGW, the ureteroscopy is performed without SGW.
A - with SGW
Ureteroscopy with SGW in place.
Ureteroscopy with and without safety guidewire
In study arm A - with SGW, endoscopic treatment is performed with a safety guidewire in place. In study arm B - without SGW, the ureteroscopy is performed without SGW.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ureteroscopy with and without safety guidewire
In study arm A - with SGW, endoscopic treatment is performed with a safety guidewire in place. In study arm B - without SGW, the ureteroscopy is performed without SGW.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helse-Bergen HF
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Helse-Bergen HF, Haukeland University Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Øyvind Ulvik, MD
Role: PRINCIPAL_INVESTIGATOR
Helse Bergen HF, Haukeland University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helse Bergen HF, Haukeland University Hospital
Bergen, Bergen, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21835 (NSD) - 3
Identifier Type: OTHER
Identifier Source: secondary_id
102.09 (REK) - 3
Identifier Type: OTHER
Identifier Source: secondary_id
102.09 (REK) - 3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.